Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 13.07.2026 5 AIDS 1 AIDS Res Hum Retroviruses 1 Ann Intern Med 2 BMC Cancer 3 Clin Infect Dis 1 Drugs 4 HIV Med 1 J Infect Dis 4 J Med Virol 1 J Virol 1 Lancet 1 N Engl J Med 1 Nat Med 4 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. NAWFAL ES, Sheehan DM, Ibanez G, Hayes T, et al
   HIV-related stigma, antiretroviral adherence, and viral suppression among women with HIV: the role of anxiety and patient-provider relationship.
   AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004575.
   PubMed         Abstract available
   
   
2. BOBADILLA R, Tenenbaum TL, Vanpouille C, Wells A, et al
   Impact of influenza and pneumococcal vaccines on inflammatory response during suppressive antiretroviral therapy.
   AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004580.
   PubMed         Abstract available
   
   
3. TIMIRYASOVA A, Greenberg L, Domingo P, Tarr PE, et al
   CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.
   AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004579.
   PubMed         Abstract available
   
   
4. BENLARBI M, Andalibi MS, Belanger E, Tauzin A, et al
   HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.
   AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004578.
   PubMed         Abstract available
   
   
5. BROUILLETTE MJ, Scott SC, Harris M, Thomas R, et al
   Vascular risk drives cognitive decline over 10 years in people aging with well-controlled HIV.
   AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004576.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

6. LI J, Zhou M, Guo H, Huang L, et al
   Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy.
   AIDS Res Hum Retroviruses. 2026 Jul 8:8892229261468110.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

7. MILLARD PS
   In HIV-1, bictegravir-lenacapavir was noninferior to continued complex regimens for maintaining viral suppression at 48 wk.
   Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-26-02075.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. NOGUERAS-GONZALEZ GM, Inam ME, Msadabwe S, Lee KL, et al
   Impact of social determinants of health on cervical cancer stage at presentation among women in Zambia: a cross-sectional single-center epidemiological study.
   BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16315.
   PubMed         Abstract available
   
   
9. ZHOU Y, Lau B, Rudolph JE, Xu X, et al
   Sex- and age- specific lung cancer incidence and mortality among Medicaid beneficiaries with and without HIV, 2001-2015.
   BMC Cancer. 2026 Jul 7. doi: 10.1186/s12885-026-16487.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

10. MAZZITELLI M, Parczewski M, Burger D, Wensing A, et al
    Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications.
    Clin Infect Dis. 2026 Mar 11:ciag046. doi: 10.1093.
    PubMed         Abstract available
    
    
11. CHAKRAWARTI A, Cromarty RT, Basting CM, Anderson J, et al
    Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.
    Clin Infect Dis. 2026 Jul 6:ciag369. doi: 10.1093.
    PubMed         Abstract available
    
    
12. JONES T, Lefebvre M, Reyes O, Dalton J, et al
    Fever in a Man with Uncontrolled HIV.
    Clin Infect Dis. 2026;82:1091-1095.
    PubMed        
    
    

    
    Drugs

13. ADEPOJU VA, Abdulrahim A, Biswas S
    The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.
    Drugs. 2026 Jul 4. doi: 10.1007/s40265-026-02359.
    PubMed         Abstract available
    
    

    
    HIV Med

14. GIROMETTI N, Hill A, Simmons B, Byrne R, et al
    Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort study.
    HIV Med. 2026 Jul 5. doi: 10.1111/hiv.70283.
    PubMed         Abstract available
    
    
15. PIERCE AB, Krishnaswamy S, Rawson-Harris P, Fatima W, et al
    Menopause and comorbidity assessment in cisgender women living with HIV in Victoria: A clinic record review of women seen at three tertiary centres in Melbourne, Australia.
    HIV Med. 2026 Jul 5. doi: 10.1111/hiv.70281.
    PubMed         Abstract available
    
    
16. BACQUART S, Palich R, Veyri M, Bregigeon-Ronot S, et al
    Outcomes of Kaposi sarcoma in people living with HIV who maintain long-term viral suppression: A prospective case-series.
    HIV Med. 2026 Jul 8. doi: 10.1111/hiv.70280.
    PubMed         Abstract available
    
    
17. DEJENE BE, Assabie Y, Tadele M, Adnew B, et al
    Artificial intelligence for predicting antiretroviral therapy outcomes in people living with HIV: A systematic review of predictive models, predictors and clinical readiness.
    HIV Med. 2026 Jul 8. doi: 10.1111/hiv.70277.
    PubMed         Abstract available
    
    

    
    J Infect Dis

18. MELENDEZ JH, Onzia AA, Mande E, Tirado AM, et al
    Pharyngeal gonorrhea in Ugandan men with urogenital gonorrhea: differences in antimicrobial resistance and strain types between anatomical sites.
    J Infect Dis. 2026 Jul 8:jiag353. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

19. GAN L, Xie X, Fu Y, Yang X, et al
    Metabolic and Immunological Trajectories and Virological Outcomes of Ainuovirine-Based Antiretroviral Therapy: A 48-Week Longitudinal Cohort Study in Treatment-Naive Adults.
    J Med Virol. 2026;98:e71038.
    PubMed         Abstract available
    
    
20. GOSSET PE, Margueron-Sentis C, Ramiere C, Zoulim F, et al
    Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study.
    J Med Virol. 2026;98:e71050.
    PubMed         Abstract available
    
    
21. MA J, Wang X, Sarkar P, He J, et al
    JQKD82 Inhibits HIV Infection of Macrophages Through Blocking Viral Entry and Enhancing Antiviral ISG Responses.
    J Med Virol. 2026;98:e71043.
    PubMed         Abstract available
    
    
22. ARRAMBIDE CAJ, Karampoor S, Abdelrahim IM, Maloletneva NV, et al
    Hijacking the Host: Post-Translational Modifications as Molecular Switches in HIV Persistence and Immune Evasion.
    J Med Virol. 2026;98:e71048.
    PubMed         Abstract available
    
    

    
    J Virol

23. OMONDI FH, Shahid A, Kinloch NN, Dong W, et al
    HIV superinfection reveals sequential reservoir reactivation and immune-driven rebound dynamics.
    J Virol. 2026 Jul 10:e0047326. doi: 10.1128/jvi.00473.
    PubMed         Abstract available
    
    

    
    Lancet

24. THE LANCET
    Ending HIV: a reality check.
    Lancet. 2026;408:93.
    PubMed        
    
    

    
    N Engl J Med

25. SEIB KL, Donovan B, Jin F, Thng C, et al
    Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection.
    N Engl J Med. 2026 Jul 8. doi: 10.1056/NEJMoa2516739.
    PubMed         Abstract available
    
    

    
    Nat Med

26. THEODORE DA, Mayer BT, Rolle CP, DeJesus E, et al
    Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.
    Nat Med. 2026 Jul 7. doi: 10.1038/s41591-026-04472.
    PubMed         Abstract available
    
    

    
    PLoS One

27. KINOKO DW, Kavindi AC, Yuda P, Tibenderana JR, et al
    Determinants of HIV testing uptake among adolescent girls and young women in mainland Tanzania: A stratified analysis of the 2016/17 and 2022/2023 national surveys.
    PLoS One. 2026;21:e0343753.
    PubMed         Abstract available
    
    
28. SHARIFI R, Nejadghaderi SA, Mohammadi F, Kharazifard MJ, et al
    The burden and epidemiology of orofacial clefts in Iran from 1990 to 2023: a Global Burden of Disease study with subnational socio-demographic index analysis.
    PLoS One. 2026;21:e0352804.
    PubMed         Abstract available
    
    
29. SUTER A, Bickel M, Depmeier C, Gute P, et al
    A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.
    PLoS One. 2026;21:e0351576.
    PubMed         Abstract available
    
    
30. IIDA K, Mori H, Remez D, Krokva D, et al
    Epidemiological characteristics of amebiasis in Japan from 2001 to 2022.
    PLoS One. 2026;21:e0318901.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

31. ZHAO Y, Probert S, Birkel J, Liu X, et al
    Independent proviral and antiviral host factors recognize the same capsid protein in divergent human herpesviruses.
    PLoS Pathog. 2026;22:e1014376.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. MELCAK I, Slack RL, Lorson ZC, Emanuelli Castaner A, et al
    HIV-1 capsid interactions with Nuclear Pore Complex components support nuclear entry via affinity gradient.
    Proc Natl Acad Sci U S A. 2026;123:e2534919123.
    PubMed         Abstract available
    
    

    
    Virology

33. TERZOPOULOS N, Tiplady O, Pan Q, Liang C, et al
    Development of a virus particle fusion assay to study and target virus entry.
    Virology. 2026;623:111025.
    PubMed         Abstract available
    
    
34. NAKAMURA Y, Ahagon-Edamura A, Koga R, Shimagaki K, et al
    Regulation of HIV-2 Vpx/Vpr expression by the poly-proline motif: Enhancement of protein dimerization and translation.
    Virology. 2026;623:111016.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum